STOCK TITAN

SNDL Inc. (NASDAQ: SNDL) gains 66.7% economic exposure to Parallel assets

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

SNDL Inc. completed the Parallel Transaction, acquiring operating assets of Surterra Holdings and affiliates in Florida, Texas and Massachusetts through a strict foreclosure and related restructuring. Via its Sunstream joint venture, SNDL now has indirect majority economic exposure to 66.7% of TransactionCo’s equity and 69.4% of its debt.

The acquired platform includes 56 retail locations and three cultivation and manufacturing facilities with annualized revenue of about US$150 million, contributing to what CEO Zach George described as a 249-store global cannabis retail network. The restructuring extinguished approximately US$842 million of Parallel debt and leaves SNDL positioned to seek direct, consolidated exposure to U.S. medical cannabis operations, subject to legal, regulatory, accounting and Nasdaq requirements. A US$29.75 million loan position was also acquired at a 25% discount and continues to be accounted for using the equity method, with broader financial reporting changes expected once SNDL secures direct operational control.

Positive

  • Completion of the Parallel Transaction gives SNDL, via Sunstream, majority economic exposure to U.S. medical cannabis assets with about US$150 million annualized revenue, while extinguishing roughly US$842 million of Parallel debt and supporting a 249-store global cannabis retail network.

Negative

  • None.

Filing Explained

The transaction is complete, but it has not yet changed SNDL’s financial reporting: its indirect exposure remains accounted for under the equity method, while direct holdings and consolidation—and any resulting gain, loss, impairment or other statement effect—remain subject to required steps and analysis.

Annualized revenue of acquired assets US$150 million Annualized revenue of Parallel operating assets in Florida, Texas and Massachusetts
Debt extinguished in Parallel Transaction approximately US$842 million Debt obligations of Parallel eliminated through the strict foreclosure restructuring
Initial secured loan to Parallel US$150 million Secured loan provided by Talladega LP to Parallel on May 7, 2021
Loan position acquired from PE Fund LP US$29.75 million Principal loan purchased at a 25% discount to par and accounted for using the equity method
Economic exposure to TransactionCo equity 66.7% Indirect majority economic exposure to TransactionCo’s equity via Sunstream joint venture
Economic exposure to TransactionCo debt 69.4% Indirect exposure to TransactionCo’s debt via Sunstream joint venture
Retail locations acquired from Parallel 56 locations Operating assets across Florida, Texas and Massachusetts
Total cannabis retail network 249 stores Global cannabis retail network supported by SNDL after the Parallel Transaction, as described by the CEO
strict foreclosure regulatory
"completed pursuant to a strict foreclosure agreement, by and among SH Parent, Inc."
secured creditor foreclosure financial
"TransactionCo completed a consensual secured creditor foreclosure of specified equity interests"
vertically integrated technical
"a U.S. vertically integrated cannabis operator with state-licensed operations"
Vertically integrated describes a company that owns and controls multiple steps in making and selling its products or services — for example sourcing raw materials, manufacturing, and distribution. Like a bakery that grows its own wheat, mills the flour, bakes the bread and runs the shops, this setup can lower costs, improve quality and speed to market and protect profit margins, but it also requires more capital and can reduce flexibility.
deconsolidated financial
"adult-use or recreational exposure, including in Massachusetts, to remain deconsolidated"
International Financial Reporting Standards financial
"accounted for using the equity method under International Financial Reporting Standards"
International Financial Reporting Standards are a common set of accounting rules used by companies in many countries to prepare and present their financial statements. They matter to investors because they make results easier to compare across borders — like using the same measuring tape — so investors can assess profitability, cash flow and risk more reliably and spot differences that come from business performance rather than differing accounting methods.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What major transaction did SNDL (SNDL) announce on this Form 6-K?

SNDL announced completion of the Parallel Transaction, acquiring operating assets of Surterra Holdings and affiliates in Florida, Texas and Massachusetts through a strict foreclosure and restructuring, executed via TransactionCo and the Sunstream joint venture to gain majority economic exposure to the U.S. operations.

What assets and markets did SNDL (SNDL) gain through the Parallel Transaction?

The acquired platform includes 56 retail locations and 3 cultivation and manufacturing facilities across Florida, Texas and Massachusetts, with brands such as Surterra Wellness, Goodblend and NETA, adding to SNDL’s cannabis retail network and expanding its presence in key U.S. medical cannabis markets.

How large are the Parallel assets in revenue and debt terms for SNDL (SNDL)?

The operating assets acquired from Parallel generate annualized revenue of about US$150 million. The restructuring extinguished approximately US$842 million of Parallel debt, following an original US$150 million secured loan and additional financings provided by Talladega LP and senior noteholders.

What economic interest does SNDL (SNDL) now hold in TransactionCo after the deal?

Through its Sunstream joint venture, SNDL has indirect majority economic exposure equivalent to ownership of 66.7% of TransactionCo’s equity and 69.4% of its debt, tied to Parallel’s U.S. medical cannabis operations in Florida, Texas and Massachusetts, with potential future consolidation into SNDL’s results.

How will the Parallel Transaction initially affect SNDL (SNDL)'s financial reporting?

Initially, there is no broad change to SNDL’s reporting beyond acquiring a US$29.75 million loan at a 25% discount, which remains equity-method accounted under IFRS. Consolidation of TransactionCo’s medical business is expected only once SNDL converts its indirect exposure into direct majority ownership and operational control.

What is SNDL (SNDL)'s overall retail footprint after this transaction?

CEO Zach George stated that SNDL now supports a 249-store cannabis retail network globally, described as the largest by store count, including the 56 Parallel locations: 43 dispensaries in Florida, 10 locations in Texas and 3 dispensaries in Massachusetts.

What key risks does SNDL (SNDL) highlight regarding the Parallel Transaction?

SNDL cites risks including the illegality of cannabis under U.S. federal law, possible changes in federal or state regulations, licence maintenance and renewal, liquidity and financing risks, valuation and collectability of acquired debt interests, governance and listing compliance matters, and the ability to achieve planned consolidation and profitability.
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File Number: 001-39005

SNDL Inc.
(Translation of registrant's name into English)

#101, 17220 Stony Plain Road NW
Edmonton, AB T5S 1K6
Tel.: (780) 944-9994

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [   ]      Form 40-F [ X ]

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      SNDL Inc.    
  (Registrant)
   
  
Date: July 27, 2026     /s/ Alberto Paredero Quiros    
  Alberto Paredero Quiros
  Chief Financial Officer
  


EXHIBIT INDEX

Exhibit Number Description
   
99.1 Press Release dated July 27, 2026

EXHIBIT 99.1

SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations

EDMONTON, Alberta, July 27, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) today announced the completion of the acquisition of certain assets of Surterra Holdings, Inc. and certain of its affiliates (collectively, “Parallel”), a U.S. vertically integrated cannabis operator with state-licensed operations in Florida, Texas and Massachusetts (the “Parallel Transaction”). The Parallel Transaction was previously announced on April 29, 2026.

The Parallel Transaction was completed pursuant to a strict foreclosure agreement, by and among SH Parent, Inc., Surterra Holdings, Inc., certain of their subsidiaries and CDXX TransCo, LLC (“TransactionCo”), together with a related contribution and exchange agreement among TransactionCo and participating Parallel creditors. Through the Parallel Transaction, TransactionCo completed a consensual secured creditor foreclosure of specified equity interests and assets associated with Parallel’s operations in Florida, Texas and Massachusetts. The Parallel Transaction substantially reduces Parallel’s legacy debt burden and provides SNDL, through its Sunstream Bancorp Inc. (“Sunstream”) joint venture, with indirect majority economic exposure equivalent to ownership of 66.7% of TransactionCo’s equity and 69.4% of its debt. The Company expects to be able to convert this indirect exposure in TransactionCo and its subsidiaries into direct, consolidated holdings in the coming months, subject to applicable legal, regulatory, accounting and Nasdaq requirements, resulting in SNDL becoming one of the first Nasdaq-listed companies to have direct, consolidated exposure to U.S. medical cannabis operations. Consistent with recent public uplisting precedents, SNDL expects any adult-use or recreational exposure, including in Massachusetts, to remain deconsolidated unless and until Nasdaq, applicable law, contractual arrangements, and accounting standards permit a different treatment.

“Closing the Parallel Transaction marks the successful completion of a complex, multi-year restructuring of one of Sunstream’s largest legacy credit investments and represents a defining milestone in our strategy to become a leading vertically integrated North American cannabis company,” said Zach George, Chief Executive Officer of SNDL. "SNDL now supports a 249-store cannabis retail network, the largest in the world by store count. We believe that the operating discipline, retail expertise and lessons learned from Canada’s intensely competitive cannabis market - including navigating regulatory complexity and excessive tax rates - will serve us well as we expand in key U.S. medical cannabis markets such as Florida, Massachusetts, and Texas. Coupled with our strong balance sheet and access to capital, SNDL is uniquely positioned to pursue disciplined growth and strategic consolidation to create long-term value for shareholders.”  

Operating Platform

The operating assets acquired from Parallel include 56 retail locations and 3 cultivation and manufacturing facilities across Florida, Texas and Massachusetts. With annualized revenue of approximately US$150 million and a profitable foundation, the assets acquired from Parallel represent an attractive expansion platform following consolidation, with additional opportunities to accelerate growth and further enhance profitability. The existing footprint includes:

  • Florida: 43 dispensaries operating under the Surterra Wellness brand from a single cultivation and production facility comprising approximately 175,000 square feet.
  • Texas: 10 retail or pickup locations operating under the Goodblend brand from a single cultivation and production facility. Goodblend is one of only three active licensed operators serving Texas’ approximately 31.7 million residents, a population roughly 35% larger than Florida and more than three-quarters the size of Canada.
  • Massachusetts: 3 dispensaries operating under the New England Treatment Access (“NETA”) brand and 1 cultivation and production facility comprising approximately 19,600 square feet.

Background to the Parallel Transaction

Talladega LP (“Talledega”), a partnership, wholly owned by affiliates of Sunstream, initially provided Parallel with a US$150 million secured loan on May 7, 2021 (the “Initial Loan”), secured by a junior security interest in substantially all of Parallel’s assets and a senior security interest in Parallel’s Massachusetts-based business. Parallel subsequently defaulted on the Initial Loan and indebtedness owing under its senior secured notes. Following the default, Talladega and certain senior noteholders (the “Senior Noteholders”) provided additional financing to preserve enterprise value while Parallel pursued strategic alternatives. These financings were ultimately addressed as part of the restructuring completed through a foreclosure agreement. After an extensive marketing process that did not result in an acceptable third-party transaction, Parallel, Talladega and the Senior Noteholders pursued the strict foreclosure Parallel Transaction completed today. The Parallel Transaction converted specified pre-closing creditor claims into a combination of new debt and ownership interests in TransactionCo and its subsidiaries. The Parallel Transaction extinguished approximately US$842 million of debt obligations of Parallel and establishes a more sustainable capital structure for the acquired business.

Financial Reporting

The closing of the Parallel Transaction does not have any immediate impact on SNDL’s financial reporting, other than the acquisition of the US$29.75 million principal loan position from PE Fund LP, which was acquired at a 25% discount to par value. This investment continues to be accounted for using the equity method under International Financial Reporting Standards based on SNDL’s indirect economic exposure. A change in financial reporting will occur once SNDL is in a position to convert its current indirect exposure into a direct majority equity and debt exposure that is expected to result in operational control and the consolidation of TransactionCo’s medical business. The final accounting classification and valuation of SNDL’s future direct interests, and any resulting gain, loss, impairment or other impact on the financial statements, remain subject to the completion of the required legal and regulatory steps, and applicable accounting and valuation analyses.

Advisors

Weil, Gotshal & Manges LLP is acting as legal counsel for Sunstream and Talladega. Moelis & Company is acting as the exclusive financial advisor and investment banker to Sunstream and Talladega.

ABOUT SNDL INC.

SNDL Inc. (NASDAQ: SNDL, CSE: SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis companies and the largest private-sector liquor and cannabis retailer in Canada, with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf and Cost Cannabis. With products available in licensed cannabis retail locations nationally, SNDL’s consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future and Bhang Chocolate. SNDL’s investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the North American cannabis industry. For more information, please visit www.sndl.com.

For more information:
Tomas Bottger
Investor Relations, SNDL Inc.
O: 1.587.327.2017
E: investors@sndl.com

FORWARD-LOOKING INFORMATION

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”), including, but not limited to statements regarding the anticipated benefits of the Parallel Transaction, Parallel’s post-closing capital structure and path toward profitability, future operations, financial condition and performance of Parallel and the acquired businesses, the ability of Sunstream or SNDL to preserve or realize value from the restructuring, the continued compliance of the Sunstream structure with applicable laws and listing requirements, the potential conversion of indirect to direct holdings in Parallel, any future path to increased economic exposure, ownership, operational integration, uplisting-related treatment or consolidation by SNDL, future investments by Sunstream, and the expected accounting treatment and financial reporting implications of the Parallel Transaction. Forward-looking statements are frequently characterized by words such as “plan,” “continue,” “expect,” “project,” “intend,” “believe,” “anticipate,” “estimate,” “likely,” “outlook,” “forecast,” “may,” “will,” “potential,” “proposed” and similar words, or statements that certain events or conditions “may” or “will” occur. These statements are predictions based on assumptions, estimates, analyses and opinions considered reasonable as of the date made, including assumptions regarding the market size, continued validity of licences and regulatory approvals, the availability of financing and liquidity, the ability of the acquired businesses to execute their operating plans and service their indebtedness, the interpretation and application of U.S. federal and state cannabis laws and the accounting and valuation of the relevant debt and equity interests and there being no negative changes in the regulatory landscape. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual events or results to differ materially. These include risks relating to the illegality of cannabis under U.S. federal law, changes in federal or state laws, regulations or enforcement priorities, the maintenance, transfer or renewal of licences, operating, integration, liquidity and financing risks, the availability of working capital, the ability of Parallel and its subsidiaries to service the post-closing senior secured term loans, the collectability, priority, enforceability and valuation of the debt interests acquired, the difference between the face amount, purchase price and fair value of the acquired debt, adverse market and competitive conditions, the ability of Parallel to achieve its business plan, disputes among stakeholders, governance and control matters, listing compliance matters, the satisfaction of conditions to any exchange, increased exposure or consolidation; and accounting and valuation determinations.   Readers should review the risk factors described in SNDL’s Annual Information Form dated March 11, 2026 and in SNDL’s other public disclosure documents filed with Canadian securities regulators and available under SNDL’s profiles on SEDAR+ at www.sedarplus.ca and with the Securities and Exchange Commission through EDGAR at www.sec.gov/edgar. In respect of the forward-looking statements and forward-looking information, SNDL have provided such statements and information in reliance on certain assumptions that they believe are reasonable at this time. SNDL believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information or statements and no assurance can be given that such events will occur in the disclosed time frames or at all. Should one or more of the foregoing risks or uncertainties materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although SNDL has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and SNDL does not undertake any obligation to publicly update such forward-looking information or forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

Filing Exhibits & Attachments

1 document